Joint Pharmaceutical Analysis Group, pharmaceutical industry analysis.#Pharmaceutical #industry #analysis

Posted On Feb 9 2018 by

pharmaceutical industry analysis run for pharmaceutical analysts by pharmaceutical analysts NEXT EVENT: Tuesday 28th November 2017 – The pharmaceutical analysis postgraduate research awards and careers symposium. JPAG plans and delivers events that address all aspects of pharmaceutical analysis and related facets of medicine control & registration. The pharmaceutical analysis postgraduate research awards and careers symposium Royal Society of Chemistry, London JPAG presents its inaugural pharmaceutical analysis symposium for postgraduate students and early career stage scientists. This will provide the opportunity for delegates to showcase their work and network with peers, academics and industrial scientists through podium and poster presentations.The best …


GMP Pharmaceutical Analysis Laboratories, pharmaceutical industry analysis.#Pharmaceutical #industry #analysis

Posted On Feb 9 2018 by

GMP Pharmaceutical Analysis Laboratories Our GMP pharmaceutical laboratories provide chemistry, manufacturing and controls (CMC) analytical laboratory services in accordance with current Good Manufacturing Practice (cGMP). Intertek provides cGMP compliant pharmaceutical analysis services that meet the requirements of regulatory authorities worldwide. Laboratory services supporting GMP and CMC requirements range from early development characterization, formulation support analysis, stability testing and method development and method validation through to GMP batch release testing. Our experienced scientists can support your development or manufacturing activities for both small molecule pharmaceuticals and biopharmaceuticals such as proteins, monoclonal antibodies and vaccines. Our GMP laboratory teams have extensive experience …


Pharmaceutical Technology, pharmaceutical industry analysis.#Pharmaceutical #industry #analysis

Posted On Jan 31 2018 by

pharmaceutical industry analysis Pharmaceutical Technology is using cookies We use them to give you the best experience. If you continue using our website, we’ll assume that you are happy to receive all cookies on this website. Log In Clinical Trials LIFNano: can nanotech ‘flip the switch’ to cure multiple sclerosis? Red sage: could this ancient Chinese herb prevent bone loss? Nutraceuticals are being held back by regulatory confusion Cold Chain Evocalcet faces stiff competition in Japan’s CKD-induced hyperparathyroidism market Blockchain in pharma: opportunities in the supply chain Are drug expiration dates fit for purpose? Diseases LIFNano: can nanotech ‘flip the …


International Journal of Pharmaceutical Sciences and Research (IJPSR), pharmaceutical analysis.#Pharmaceutical #analysis

Posted On Jan 21 2018 by

Review Articles Antimicrobial resistance has been called one of the world’s most pressing public health problems. Addressing the issue of antimicrobial resistance is one of the most urgent priorities in the fields of public health today. Alarmingly, the development of resistance such as multi-drug resistance towards a number of antibiotics poses a challenge to the scientific community in the discovery of new ther. A. Shaista* and P. Amrita Department of Pharmaceutical Chemistry, Delhi Pharmaceutical Science and Research University, New Delhi, India. A COMPREHENSIVE REVIEW ON HERBAL COSMETICS India is a focus for development of Ayurveda, Unani, Siddha, Homoeopathy and another …


Equity: Global Pharmaceuticals ETF: Holdings, Quote, Analysis, Ratings #pharmaceutical #industry #statistics

Posted On Dec 25 2017 by

#pharma etf # Equity: Global Pharmaceuticals ETF.com Insight Of the two choices for global pharmaceutical ETFs, neither provides a broad, neutral take on the segment. Both products take big leaps from the market portfolio in their selection and Both products take big leaps from the market portfolio weighting procedures that make them tilted takes on the global market.PPH is a descendent of the now-defunct HOLDRS ETFs, some of the earliest and simplest exchange- traded products. The current iteration of the fund is a traditional 1940 Act ETF, meaning unlike the old HOLDRS, it can reinvest dividends. The underlying index, however, …


Pharmaceutical News, Industry Analysis, Market Research Reports – Pharmaceutical Business Review #helix #pharma

Posted On Dec 24 2017 by

#pharmaceutical business # Pharmaceutical Business Review FDA approves Amgen’s BLINCYTO for pediatric acute lymphoblastic leukemia The US Food and Drug Administration (FDA) has approved Amgen’s supplemental Biologics License Application (sBLA) for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Regulatory Affairs News Biogen’s Alzheimer’s drug gets FDA fast-track status By PBR Staff Writer The US Food and Drug Administration (FDA) has granted fast track designation to Biogen’s investigational Alzheimer’s disease (AD) treatment aducanumab. Production Manufacturing Process Production News Singapore sees first case of …


DUSA – News and Analysis – DUSA Pharmaceuticals, Inc #jobs #in #pharmaceutical #industry

Posted On Dec 8 2017 by

#dusa pharma # DUSA is a vertically integrated dermatology company that is developing and marketing Levulan PDT and other products for common skin conditions. We operate in two segments, Photodynamic Therapy, or PDT, Drug and Device Products and Non-Photodynamic Therapy, or Non-PDT, Drug Products. Our Levulan® Kerastick® and BLU-U® products comprise our PDT segment, while Nicomide®, ClindaReach® and the other products acquired in the acquisition of Sirius comprise our Non-PDT segment. Our currently marketed products include among others Levulan® Kerastick® 20% Topical Solution with photodynamic therapy, the BLU-U® brand light source, and certain products acquired in the March 10, 2006 …


Pharmaceutical News, Industry Analysis, Market Research Reports – Pharmaceutical Business Review #pharma #consulting

Posted On Dec 7 2017 by

#pharmaceutical business # Pharmaceutical Business Review FDA approves Amgen’s BLINCYTO for pediatric acute lymphoblastic leukemia The US Food and Drug Administration (FDA) has approved Amgen’s supplemental Biologics License Application (sBLA) for BLINCYTO (blinatumomab) to include new data supporting the treatment of pediatric patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL). Regulatory Affairs News Biogen’s Alzheimer’s drug gets FDA fast-track status By PBR Staff Writer The US Food and Drug Administration (FDA) has granted fast track designation to Biogen’s investigational Alzheimer’s disease (AD) treatment aducanumab. Production Manufacturing Process Production News Singapore sees first case of …


GMP Pharmaceutical Analysis Laboratories #evaluate #pharma

Posted On Dec 3 2017 by

#gmp pharma # The Shale Oil and Gas Revolution has changed the energy world. Intertek has kept pace by providing crucial and timely exploration, production, quality, quantity inventory, compliance, certification, training, inspection and logistics support and expertise to an industry in radical transition. Demand for non-destructive testing (NDT) has grown and Intertek is meeting the growing market for these services. We are living a connected life, and Intertek works to ensure and optimize those connections via its testing services for the Internet of Things. The world has rules, and Intertek’s constant and continuing work in regulatory compliance brings you the …


Market Research Reports and Industry Analysis from JSB Market Research #epic #pharma

Posted On Dec 2 2017 by

#market research reports # Market Research Reports and Industry Analysis JSB Market Research Pvt.Ltd was formed in 2013 and the portal www.jsbmarketresearch.com for quality primary market research reports was launched to dedicatedly provide quick search service to global clients with no restriction to any industry verticals. We favour timeliness of deliverables as one of the prime points of business in today’s competitive market research arena. For us, the process adds value to our core business. But, as a competing firm with, JSB Market Research Pvt.Ltd is equally aligned to providing quality reports to clients. Accelerating business prospects with our market …